168 related articles for article (PubMed ID: 18955452)
1. Evolution of the randomized controlled trial in oncology over three decades.
Booth CM; Cescon DW; Wang L; Tannock IF; Krzyzanowska MK
J Clin Oncol; 2008 Nov; 26(33):5458-64. PubMed ID: 18955452
[TBL] [Abstract][Full Text] [Related]
2. Presentation of nonfinal results of randomized controlled trials at major oncology meetings.
Booth CM; Le Maître A; Ding K; Farn K; Fralick M; Phillips C; Cescon DW; Meyer RM
J Clin Oncol; 2009 Aug; 27(24):3938-44. PubMed ID: 19620490
[TBL] [Abstract][Full Text] [Related]
3. Statistical power of negative randomized controlled trials presented at American Society for Clinical Oncology annual meetings.
Bedard PL; Krzyzanowska MK; Pintilie M; Tannock IF
J Clin Oncol; 2007 Aug; 25(23):3482-7. PubMed ID: 17687153
[TBL] [Abstract][Full Text] [Related]
4. Survival end point reporting in randomized cancer clinical trials: a review of major journals.
Mathoulin-Pelissier S; Gourgou-Bourgade S; Bonnetain F; Kramar A
J Clin Oncol; 2008 Aug; 26(22):3721-6. PubMed ID: 18669458
[TBL] [Abstract][Full Text] [Related]
5. Clinical benefit in oncology trials: is this a patient-centred or tumour-centred end-point?
Ohorodnyk P; Eisenhauer EA; Booth CM
Eur J Cancer; 2009 Sep; 45(13):2249-52. PubMed ID: 19545996
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
7. Discordance between conclusions stated in the abstract and conclusions in the article: analysis of published randomized controlled trials of systemic therapy in lung cancer.
Altwairgi AK; Booth CM; Hopman WM; Baetz TD
J Clin Oncol; 2012 Oct; 30(28):3552-7. PubMed ID: 22649130
[TBL] [Abstract][Full Text] [Related]
8. Using routine data to complement and enhance the results of randomised controlled trials.
Lewsey JD; Leyland AH; Murray GD; Boddy FA
Health Technol Assess; 2000; 4(22):1-55. PubMed ID: 11074392
[TBL] [Abstract][Full Text] [Related]
9. Increasing underrepresentation of elderly patients with advanced colorectal or non-small-cell lung cancer in chemotherapy trials.
Jennens RR; Giles GG; Fox RM
Intern Med J; 2006 Apr; 36(4):216-20. PubMed ID: 16640737
[TBL] [Abstract][Full Text] [Related]
10. Pemetrexed: a multitargeted antifolate.
Rollins KD; Lindley C
Clin Ther; 2005 Sep; 27(9):1343-82. PubMed ID: 16291410
[TBL] [Abstract][Full Text] [Related]
11. Adequacy of published oncology randomized controlled trials to provide therapeutic details needed for clinical application.
Duff JM; Leather H; Walden EO; LaPlant KD; George TJ
J Natl Cancer Inst; 2010 May; 102(10):702-5. PubMed ID: 20410466
[TBL] [Abstract][Full Text] [Related]
12. Randomized controlled trials in otolaryngology journals.
Yao F; Singer M; Rosenfeld RM
Otolaryngol Head Neck Surg; 2007 Oct; 137(4):539-44. PubMed ID: 17903567
[TBL] [Abstract][Full Text] [Related]
13. An analysis of randomized controlled trials published in the US family medicine literature, 1987-1991.
Silagy CA; Jewell D; Mant D
J Fam Pract; 1994 Sep; 39(3):236-42. PubMed ID: 8077902
[TBL] [Abstract][Full Text] [Related]
14. Control of bias in randomized controlled trials published in prosthodontic journals.
Dumbrigue HB; Jones JS; Esquivel JF
J Prosthet Dent; 2001 Dec; 86(6):592-6. PubMed ID: 11753309
[TBL] [Abstract][Full Text] [Related]
15. Comparators, study duration, outcome measures and sponsorship in therapeutic trials of psoriasis: update of the EDEN Psoriasis Survey 2001-2006.
Naldi L; Svensson A; Zenoni D; Diepgen T; Elsner P; Grob JJ; Coenraads PJ; Bouwes Bavinck JN; Maccagni A; Linder D; Williams H;
Br J Dermatol; 2010 Feb; 162(2):384-9. PubMed ID: 19785620
[TBL] [Abstract][Full Text] [Related]
16. Association between pharmaceutical involvement and outcomes in breast cancer clinical trials.
Peppercorn J; Blood E; Winer E; Partridge A
Cancer; 2007 Apr; 109(7):1239-46. PubMed ID: 17326054
[TBL] [Abstract][Full Text] [Related]
17. The role of prospective randomized clinical trials in pediatric surgery: state of the art?
Moss RL; Henry MC; Dimmitt RA; Rangel S; Geraghty N; Skarsgard ED
J Pediatr Surg; 2001 Aug; 36(8):1182-6. PubMed ID: 11479852
[TBL] [Abstract][Full Text] [Related]
18. Self-reported conflicts of interest of authors, trial sponsorship, and the interpretation of editorials and related phase III trials in oncology.
Bariani GM; de Celis Ferrari AC; Hoff PM; Krzyzanowska MK; Riechelmann RP
J Clin Oncol; 2013 Jun; 31(18):2289-95. PubMed ID: 23630201
[TBL] [Abstract][Full Text] [Related]
19. Randomized controlled trials in the era of molecular oncology: methodology, biomarkers, and end points.
Kay A; Higgins J; Day AG; Meyer RM; Booth CM
Ann Oncol; 2012 Jun; 23(6):1646-51. PubMed ID: 22048151
[TBL] [Abstract][Full Text] [Related]
20. Evaluating patient-centered outcomes in the randomized controlled trial and beyond: informing the future with lessons from the past.
Booth CM
Clin Cancer Res; 2010 Dec; 16(24):5963-71. PubMed ID: 21169249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
